FindTrial
Sign In

Bronkial respons på inhaleret Mannitol

Bronkial respons på inhaleret Mannitol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-003765-40-DK
Enrollment
Unknown
Registered
2007-07-03
Start date
2007-07-09
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A population study of the response to Aridol, used as an asthma diagnostic

Interventions

Trade Name: Aridol Product Name: Aridol Pharmaceutical Form: Powder for nebuliser solution

Sponsors

Organisation name was not entered
Lead Sponsor
Respiratory research UNit
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All subjects with a FEV1 > 70% and no respiratory infection the last 6 weeks Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: opposite of the inclusion

Design outcomes

Primary

MeasureTime frame
Main Objective: 1. Frequency of asthma 2. Frequency of AHR to mannitol and methacholine 3. Association between AHR to mannitol and methacholine ;Secondary Objective: ;Primary end point(s): Number of subjects with PD20 < 15%—

Countries

Denmark

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026